packageLenalidomide

lenalidomide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lenalidomide is an immunomodulating and anti-angiogenic drug used to treat blood cancers and related disorders, including multiple myeloma, myelodysplastic syndromes, and several types of lymphoma and leukemia. It is approved and widely used, with several authorised products in the European Union, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q425681 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lenalidomide
ATC codes:L04AX04
DrugBank:DB00480
PubChem CID:216326
ChEBI:63791
Wikidata:Q425681
formula:C13H13N3O3
molar mass:259.265 g/mol (PubChem CID 216326)
logP:-0.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown